Sawai To Expand Capacity For Oral Generics 30 Percent By 2012
This article was originally published in PharmAsia News
Sawai Pharmaceutical of Japan says it plans to expand its production capacity for oral generic drugs by nearly a third over the next two years
You may also be interested in...
Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement.
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.
The Swiss company is planning a US trial of CBSO, the first transcatheter septal occluder with a bioresorbable, metal-free frame.